XIST was reported to endorse TGF-β-stimulated epithelial-mesenchymal transition (EMT) via targeting miR-367/miR-141-ZEB2 signaling in NSCLC [21]. The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.